Workplace drug testing laws continue to evolve, creating new compliance challenges for employers and drug testing professionals. Changes at the state and federal levels can affect everything from when testing is permitted to how to address marijuana, employee protections, and testing policies.
This webinar, presented by Bill Judge, JD., LL.M. & Nick Hartman from Drug Screening Compliance Institute (DSCI), will provide a timely update on key legal and regulatory developments affecting workplace drug and alcohol testing programs. We’ll examine recent state law changes, take a closer look at significant changes affecting drug testing programs across the U.S., and discuss the implications of federal marijuana rescheduling for employers and testing programs.
Attendees will leave with a clearer understanding of what has changed, where compliance risks may exist, and what employers should review in their workplace drug and alcohol testing policies and procedures.
Learning Objectives
By the end of this webinar, attendees will be able to:
- Identify recent state and federal drug testing law developments that may affect workplace testing policies and practices.
- Understand significant changes in testing trends and what employers conducting testing should know about their programs.
- Examine federal marijuana rescheduling and what Schedule III status may—and may not—mean for workplace drug testing.
- Recognize potential compliance gaps created by changing marijuana laws, employee protections, and testing requirements.
- Identify practical steps employers should consider when reviewing and updating workplace drug and alcohol testing policies and procedures.
Date: November 17th, 2026
Time: 1 pm – 2 pm CST (1 hour)
